<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">16953394</PMID>
        <DateCompleted>
            <Year>2007</Year>
            <Month>10</Month>
            <Day>16</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0172-8172</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>27</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2007</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Rheumatology international</Title>
                <ISOAbbreviation>Rheumatol Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of glucosamine administration on patients with rheumatoid arthritis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>213-8</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>The purpose of this study was to examine whether glucosamine has an antirheumatic effect in a randomized placebo-controlled study. The subjects were 51 rheumatoid arthritis (RA) patients: 25 patients in the glucosamine group and 26 patients in the placebo group. Glucosamine hydrochloride at a daily dose of 1,500 mg and placebo, respectively, were administered for 12 weeks along with conventional medication. While significant improvement was not found in joint counts and in the rate of ACR20 responders, the face scale and a visual analogue scale pain were significantly in favor of the glucosamine group. ESR and CRP levels did not change, but serum MMP-3 levels decreased in the glucosamine group. Results of the patients' self-evaluations and the physicians' global evaluations indicated that the glucosamine treatment produced noticeable improvements in symptoms. Although glucosamine administration had no antirheumatic effect evaluated by conventional measures, it seemed to have some symptomatic effects on RA.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nakamura</LastName>
                    <ForeName>Hiroshi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Joint Disease and Rheumatism, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. nakamura@nms.ac.jp</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Masuko</LastName>
                    <ForeName>Kayo</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yudoh</LastName>
                    <ForeName>Kazuo</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kato</LastName>
                    <ForeName>Tomohiro</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kamada</LastName>
                    <ForeName>Toshikazu</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kawahara</LastName>
                    <ForeName>Tohru</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2006</Year>
                <Month>09</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Rheumatol Int</MedlineTA>
            <NlmUniqueID>8206885</NlmUniqueID>
            <ISSNLinking>0172-8172</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>EC 3.4.24.17</RegistryNumber>
                <NameOfSubstance UI="D019278">Matrix Metalloproteinase 3</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N08U5BOQ1K</RegistryNumber>
                <NameOfSubstance UI="D005944">Glucosamine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018771" MajorTopicYN="N">Arthralgia</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005944" MajorTopicYN="N">Glucosamine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019278" MajorTopicYN="N">Matrix Metalloproteinase 3</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2005</Year>
                <Month>06</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2006</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2006</Year>
                <Month>9</Month>
                <Day>6</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2007</Year>
                <Month>10</Month>
                <Day>17</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2006</Year>
                <Month>9</Month>
                <Day>6</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">16953394</ArticleId>
            <ArticleId IdType="doi">10.1007/s00296-006-0197-1</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 1999 Dec 4;354(9194):1932-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10622295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2001 Jan 27;357(9252):251-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11214126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Feb 23;354(8):795-808</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16495392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 1995 Jan;38(1):44-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7818570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 2000 Apr;43(4):852-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10765930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Osteoarthritis Cartilage. 2003 Jun;11(6):424-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12801482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Rheumatol. 2001 Jun;28(6):1347-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11409130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rheumatology (Oxford). 1999 Nov;38(11):1081-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10556259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intern Med J. 2002 May-Jun;32(5-6):208-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12036218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Osteoarthritis Cartilage. 2003 Apr;11(4):290-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12681956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Rheumatol. 2004 May-Jun;22(3):293-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15144122</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3358796</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 1995 Jun;38(6):727-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7779114</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Vet Res. 2003 Jun;64(6):666-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12828249</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 1986 Jul;29(7):906-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3741503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2000 Mar 15;283(11):1469-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10732937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 1989 Aug;48(8):645-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2675782</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
